Drusano, G. L., Yuen, G. J., Morse, G., Cooley, T. P., Seidlin, M., Lambert, J. S., . . . Dolin, R. (1992). Impact of bioavailability on determination of the maximal tolerated dose of 2',3'-dideoxyinosine in phase I trials.
Styl ChicagoDrusano, G L., G J. Yuen, G. Morse, T P. Cooley, M. Seidlin, J S. Lambert, H A. Liebman, F T. Valentine, a R. Dolin. Impact of Bioavailability On Determination of the Maximal Tolerated Dose of 2',3'-dideoxyinosine in Phase I Trials. 1992.
Citace podle MLADrusano, G L., et al. Impact of Bioavailability On Determination of the Maximal Tolerated Dose of 2',3'-dideoxyinosine in Phase I Trials. 1992.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..